1. Home
  2. ARTL vs IRTC Comparison

ARTL vs IRTC Comparison

Compare ARTL & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • IRTC
  • Stock Information
  • Founded
  • ARTL 2011
  • IRTC 2006
  • Country
  • ARTL United States
  • IRTC United States
  • Employees
  • ARTL N/A
  • IRTC N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • IRTC Medical/Dental Instruments
  • Sector
  • ARTL Health Care
  • IRTC Health Care
  • Exchange
  • ARTL Nasdaq
  • IRTC Nasdaq
  • Market Cap
  • ARTL 3.6M
  • IRTC 3.5B
  • IPO Year
  • ARTL N/A
  • IRTC 2016
  • Fundamental
  • Price
  • ARTL $0.99
  • IRTC $98.00
  • Analyst Decision
  • ARTL Strong Buy
  • IRTC Strong Buy
  • Analyst Count
  • ARTL 2
  • IRTC 10
  • Target Price
  • ARTL $5.50
  • IRTC $120.20
  • AVG Volume (30 Days)
  • ARTL 27.6K
  • IRTC 522.5K
  • Earning Date
  • ARTL 03-03-2025
  • IRTC 05-01-2025
  • Dividend Yield
  • ARTL N/A
  • IRTC N/A
  • EPS Growth
  • ARTL N/A
  • IRTC N/A
  • EPS
  • ARTL N/A
  • IRTC N/A
  • Revenue
  • ARTL N/A
  • IRTC $591,839,000.00
  • Revenue This Year
  • ARTL N/A
  • IRTC $17.10
  • Revenue Next Year
  • ARTL N/A
  • IRTC $17.19
  • P/E Ratio
  • ARTL N/A
  • IRTC N/A
  • Revenue Growth
  • ARTL N/A
  • IRTC 20.13
  • 52 Week Low
  • ARTL $0.91
  • IRTC $55.92
  • 52 Week High
  • ARTL $1.70
  • IRTC $128.52
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 33.46
  • IRTC 34.70
  • Support Level
  • ARTL $0.97
  • IRTC $104.71
  • Resistance Level
  • ARTL $1.08
  • IRTC $111.47
  • Average True Range (ATR)
  • ARTL 0.06
  • IRTC 5.95
  • MACD
  • ARTL -0.02
  • IRTC -2.02
  • Stochastic Oscillator
  • ARTL 12.28
  • IRTC 7.56

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.

About IRTC iRhythm Technologies Inc.

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

Share on Social Networks: